The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001
Open accessAbstract
We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database.Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to control, to an unusually great extent, for the effects of other potential determinants of longevity, e.g.education, income, nutrition, the environment, and "lifestyle".We find that launches of new chemical entities (NCEs) have a strong positive impact on the probability of survival.Launches of (older) drugs that are not NCEs do not increase longevity.NCE launches account for a significant fraction of the long-run increase in longevity in the sample as a whole.Between 1986 and 2000, average life expectancy of the entire population of sample countries increased by almost two years.Our estimates imply that NCE launches accounted for 0.8 years (40%) of the 1986-2000 increase in longevity.The average annual increase in life expectancy of the entire population resulting from NCE launches is .056years, or 2.93 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endogenous Technological Change
Romer, P. M. (1990) · Journal of Political Economy · doi:10.1086/261725 · Cited by 17,711
Cited by
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
Acemoglu, D., & Linn, J. (2004) · The Quarterly Journal of Economics · doi:10.1162/0033553041502144 · Cited by 967
Planning cancer control in Latin America and the Caribbean
Goss, P. E., Lee, B. L., Badovinac-Crnjevic, T., Strasser-Weippl, K., Chavarri-Guerra, Y., Louis, J. S., Villarreal-Garza, C., Unger-Saldaña, K., Ferreyra, M., Debiasi, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70048-2 · Cited by 499
Metadata
- Authors
- Lichtenberg, F. R.
- Venue
- International Journal of Health Care Finance and Economics
- Published
- 2005-03
- Volume
- 5
- Issue
- 1
- Pages
- 47-73
- ISSN
- 1389-6563 (ISSN-L)
- 1573-6962
- OpenAlex
- W1970111819
- Cited by
- 200
- References
- 1
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001. https://app.cochat.ai/papers/10.1007/s10754-005-6601-7
- The paper
- Lichtenberg, F. R. (2005). The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001. International Journal of Health Care Finance and Economics. https://doi.org/10.1007/s10754-005-6601-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.